Zydus announces USFDA Orphan Drug Designation to Usnoflast for the treatment of Amyotrophic Lateral Sclerosis (ALS) Read more
Glenmark Pharmaceuticals Inc., USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules Read more
Zydus Lifesciences receives approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS) Read more
KL College of Pharmacy Advancing Healthcare Innovations and Research in Neuropharmacology and Novel Drug Delivery Systems Read more
VENUS REMEDIES SECURES GMP CERTIFICATION FROM MOLDOVA MINISTRY OF HEALTH FOR ANTIBIOTIC-CARBAPENEM FACILITY Read more